R&D Continuing to keep COVID-19 at bay – the pharmaphorum podcas... Flying into London recently for the Jefferies Conference, Novavax’s EVP, chief commercial officer, and chief business officer John Trizzino, together with the comp
Debates & Insight Sponsored Standing on the cusp of something great: How real-world data... REAL-WORLD EVIDENCE IN ONCOLOGY: Towards Innovative and Affordable Patient Care
Views & Analysis Despite progress, Brexit still threatens UK with relegation ... With time running out on Brexit, companies are already making long-term decisions.
Views & Analysis Accessing biosimilars: untapped potential in EU and US Though they can reduce the costs of health care, biosimilars still face challenges to access.
Views & Analysis Huge scale of Brexit threat to Europe’s medicines supplies r... New survey reveals the huge task facing pharma in keeping medicines moving around Europe after Brexit.
Views & Analysis PRIME movers: taking stock of the EMA's scheme Taking stock of one PRIME, of the EMA’s flagship market access initiatives.
News Incyte blocks US launch of Sun Pharma's alopecia drug A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.